Ascorbic acid inhibits the migration of walker 256 carcinosarcoma cells
- 1 January 2008
- journal article
- Published by Walter de Gruyter GmbH in Cellular & Molecular Biology Letters
- Vol. 13 (1) , 103-111
Abstract
The results of several experimental studies have shown that ascorbic acid inhibits tumor growth and metastasis. Ascorbic acid is an antioxidant that acts as a scavenger for a wide range of reactive oxygen species (ROS). Both tumour metastasis and cell migration have been correlated with the intracellular ROS level, so it was postulated that the inhibitory effect of ascorbic acid derivatives on cell motility may be caused by scavenging of ROS. Time-lapse analyses of Walker 256 carcinosarcoma cell migration showed that both the speed of movement and the cell displacement were inhibited by ascorbic acid applied in concentrations ranging from 10 to 250 μM. This effect correlated with a reduction in the intracellular ROS level in WC 256 cells, suggesting that ROS scavenging may be a mechanism responsible for the inhibition of WC 256 cell migration. However, another potent antioxidant, N-acetyl-L-cysteine, also efficiently decreased the intracellular ROS level in WC 256 cells, but did not affect the migration of the investigated cells. These results demonstrate that intact, unmodified ascorbic acid applied in physiologically relevant and nontoxicconcentrations exerts an inhibitory effect on the migration of WC 256 carcinosarcoma cells, and that this may be one of the factors responsible for the anti-metastatic activity of vitamin C. However, our data does not support the hypothesis that the scavenging of intracellular ROS is the main mechanism in the inhibition of cancer cell migration by ascorbic acid.Keywords
This publication has 25 references indexed in Scilit:
- Genistein inhibits the contact-stimulated migration of prostate cancer cellsCellular & Molecular Biology Letters, 2007
- Contact stimulation of prostate cancer cell migration: the role of gap junctional coupling and migration stimulated by heterotypic cell‐to‐cell contacts in determination of the metastatic phenotype of Dunning rat prostate cancer cellsBiology of the Cell, 2005
- Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissuesProceedings of the National Academy of Sciences, 2005
- Antimetastatic effect of a lipophilic ascorbic acid derivative with antioxidation through inhibition of tumor invasionCancer Chemotherapy and Pharmacology, 2005
- Inhibition of the development of metastases by dietary vitamin C:K3 combinationLife Sciences, 2004
- Requirement for, Promotion, or Inhibition by α-Tocopherol of Radical-Induced Initiation of Plasma Lipoprotein Lipid PeroxidationFree Radical Biology and Medicine, 1997
- Cell motility, a principal requirement for metastasis1991
- Direct evidence that cancer cell locomotion contributes importantly to invasionExperimental Cell Research, 1987
- High-Dose Vitamin C versus Placebo in the Treatment of Patients with Advanced Cancer Who Have Had No Prior ChemotherapyNew England Journal of Medicine, 1985
- Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer.Proceedings of the National Academy of Sciences, 1976